Citation Impact
Citing Papers
Plasmacytoid Dendritic Cell Dynamics and Alpha Interferon Production during Simian Immunodeficiency Virus Infection with a Nonpathogenic Outcome
2008 StandoutNobel
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
Diagnosis and Management of Complicated Intra-abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America
2009 Standout
Regulation of Virus-Specific CD4+ T Cell Function by Multiple Costimulatory Receptors during Chronic HIV Infection
2010
Aminoglycosides for Intra-Abdominal Infection: Equal to the Challenge?
2002
Efficacy and safety of cefepime: a systematic review and meta-analysis
2007
Characteristics of and Risk Factors for Relapse of Brucellosis in Humans
1995
T cell exhaustion
2011 Standout
Global Spread of Carbapenemase-producingEnterobacteriaceae
2011 Standout
Guillain-Barré syndrome
2016 Standout
Risk of Infectious Complications in Patients Taking Glucocorticosteroids
1989 Standout
Guillain–Barré Syndrome
2012 Standout
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
2006 Standout
Human Mycoses: Drugs and Targets for Emerging Pathogens
1994 Science
Guideline for Prevention of Surgical Site Infection, 1999
1999 Standout
Brucellosis
2005 Standout
Penetration of cefuroxime into the cerebrospinal fluid of patients with traumatic brain injury
1996
Therapeutic Drug Monitoring in the Treatment of Tuberculosis: An Update
2014
Methicillin-resistance among Turkish isolates of Staphylococcus aureus strains from nosocomial and community infections and their resistance patterns using various antimicrobial agents
1997
A Randomized, Double-Blind Study to Assess the Optimal Duration of Doxycycline Treatment for Human Brucellosis
2004
Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study
2015 Standout
An Overview of Human Brucellosis
1995 Standout
Prophylaxis against Opportunistic Infections in Patients with Human Immunodeficiency Virus Infection
2000
Effect of Aminoglycoside and β‐Lactam Combination Therapy versus β‐Lactam Monotherapy on the Emergence of Antimicrobial Resistance: A Meta‐analysis of Randomized, Controlled Trials
2005
Brucella Endocarditis: The Role of Combined Medical and Surgical Treatment
1990
Influence of microbial infections on the progression of HIV disease
1997 StandoutNobel
Echinocandin antifungal drugs
2003 Standout
Extended Broad-Spectrum -Lactamases Conferring Transferable Resistance to Newer -Lactam Agents in Enterobacteriaceae: Hospital Prevalence and Susceptibility Patterns
1988 Standout
Ciprofloxacin and Rifampicin Versus Doxycycline and Rifampicin in the Treatment of Brucellosis
1999
A Case of Brucella melitensis Endocarditis Successfully Treated by a Combination of Surgical Resection and Antibiotics
1995
Treatment of Human Brucellosis with Doxycycline plus Rifampin or Doxycycline plus Streptomycin
1992
Virus-induced autoantibody response to a transgenic viral antigen
1990 StandoutNatureNobel
Brucellosis in patients infected with the human immunodeficiency virus
1998
Treatment Options for Chronic Prostatitis due to Vancomycin-Resistant Enterococcus faecium
1998
Molecular Characterization of Methicillin-ResistantStaphylococcus aureusDisseminated in a Home Care System
2006
Vancomycin-Resistant Enterococcal Infections
2000 Standout
Clinical Practice Guidelines for Hospital‐Acquired Pneumonia and Ventilator‐Associated Pneumonia in Adults
2007
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2005 Standout
Programmed Cell Death as a Mechanism of CD4 and CD8 T Cell Deletion in AIDS: Molecular Control and Effect of Highly Active Anti‐retroviral Therapy
1999 StandoutNobel
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
2013 Standout
Liposomal Amphotericin B as Initial Therapy for Invasive Mold Infection: A Randomized Trial Comparing a High-Loading Dose Regimen with Standard Dosing (AmBiLoad Trial)
2007
Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS
2005 StandoutNobel
Molecular and cellular insights into T cell exhaustion
2015 Standout
Recognition and Optimum Treatment of Brucellosis
1997
Nonpathogenic SIV Infection of Sooty Mangabeys Is Characterized by Limited Bystander Immunopathology Despite Chronic High-Level Viremia
2003
Treatment of brucella spondylitis: lessons from an impossible meta-analysis and initial report of efficacy of a fluoroquinolone-containing regimen
2004
Evaluation of the in vitro activity of six broad-spectrum β-lactam antimicrobial agents tested against over 2,000 clinical isolates from 22 medical centers in Japan
1999
Phenotype and function of myeloid dendritic cells derived from African green monkey blood monocytes
2005 StandoutNobel
Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and Children
2003 Standout
The Progressive Intercontinental Spread of Methicillin-Resistant Staphylococcus aureus
1997
Practice Guidelines for Diseases Caused by Aspergillus
2000
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
NK CELL RECOGNITION
2004 Standout
Effective treatments in the management of brucellosis
2005
Simian Immunodeficiency Virus SIVagm.sab Infection of Caribbean African Green Monkeys: a New Model for the Study of SIV Pathogenesis in Natural Hosts
2006 StandoutNobel
Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)
2013 Standout
CONTROLLED TRIAL OF PREDNISOLONE IN ACUTE POLYNEUROPATHY
1978 Standout
ZOONOTIC ENDOCARDITIS
1993
Distinct Transcriptional Profiles in Ex Vivo CD4+and CD8+T Cells Are Established Early in Human Immunodeficiency Virus Type 1 Infection and Are Characterized by a Chronic Interferon Response as Well as Extensive Transcriptional Changes in CD8+T Cells
2007
Is Streptococcus pyogenes Resistant or Susceptible to Trimethoprim-Sulfamethoxazole?
2012
Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance
1999 Standout
Development of resistance during antibiotic therapy
1987
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Primary Simian Immunodeficiency Virus SIVmnd-2 Infection in Mandrills ( Mandrillus sphinx )
2006
Klebsiella pneumoniae: Going on the Offense with a Strong Defense
2016 Standout
Optimizing ethambutol dosing among HIV/tuberculosis co-infected patients: a population pharmacokinetic modelling and simulation study
2019 StandoutNobel
Extended-Spectrum β-Lactamases: a Clinical Update
2005 Standout
Comparative Antifungal Activities and Plasma Pharmacokinetics of Micafungin (FK463) against Disseminated Candidiasis and Invasive Pulmonary Aspergillosis in Persistently Neutropenic Rabbits
2002
C1.7 Antigen Expression on CD8+ T Cells Is Activation Dependent: Increased Proportion of C1.7+CD8+ T Cells in HIV-1-Infected Patients with Progressing Disease
1999
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Cefoxitin versus Erythromycin, Neomycin, and Cefazolin in Colorectal Operations
1983
DC-SIGN from African Green Monkeys Is Expressed in Lymph Nodes and Mediates Infection intransof Simian Immunodeficiency Virus SIVagm
2003 StandoutNobel
Quinolones in treatment of human brucellosis: comparative trial of ofloxacin-rifampin versus doxycycline-rifampin
1993
Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial Resistance
2001 Standout
Review of Pseudomonas aeruginosa Meningitis with Special Emphasis on Treatment with Ceftazidime
1985
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
2010 Standout
The Crisis in Antibiotic Resistance
1992 StandoutScience
Aspergillus fumigatusand Aspergillosis
1999 Standout
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Markers of gut dysfunction do not explain low rifampicin bioavailability in HIV-associated TB
2017 StandoutNobel
Interleukin-1β Converting Enzyme–like Protease Involvement in Fas-induced and Activation-induced Peripheral Blood T Cell Apoptosis in HIV Infection. TNF-related Apoptosis-inducing Ligand Can Mediate Activation-induced T Cell Death in HIV Infection
1997
Role of cephalosporins in the treatment of bacterial meningitis in adults
1985
Practice Guidelines for the Management of Bacterial Meningitis
2004 Standout
Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS
2005 StandoutNobel
The Landry-Guillain-Barré syndrome
1977
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
Endocarditis Due to Rare and Fastidious Bacteria
2001 Standout
T helper cell activation and human retroviral pathogenesis
1996
The Biology and Detection of Immune Complexes
1980
Emergence of Resistance to Cefamandole: Possible Role of Cefoxitin-Inducible Beta-Lactamases
1979
Therapeutic Options for Infections with Enterobacteriaceae Producing Carbapenem-Hydrolyzing Enzymes
2011
Combination Therapy for Treatment of Infections with Gram-Negative Bacteria
2012
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship
2006 Standout
Impact of Viral Factors on Very Early In Vivo Replication Profiles in Simian Immunodeficiency Virus SIVagm-Infected African Green Monkeys
2005 StandoutNobel
Works of J. Kosmidis being referenced
Staphylococcal infections in hospital: the Greek experience
1988
A double-blind study of once-daily temafloxacin in the treatment of bacterial lower respiratory tract infections
1991
Ceftazidime: therapeutic results in various infections and kinetic studies
1981
International comparative study of cefepime and ceftazidime in the treatment of serious bacterial infections
1993
Factors Associated with the Development of Pneumocystis carinii Pneumonia in 5,025 European Patients with AIDS
1995
Comparison of three different regimens in the treatment of acute brucellosis: a multicenter multinational study
1989
Bioavailability of Cefuroxime in Various Sites including Bile, Sputum and Bone
1977
Cefoxitin, a New Semi-synthetic Cephamycin: An In-vitro and In-vivo Comparison with Cephalothin
1973
Complement levels in acute infectious hepatitis and serum hepatitis.
1972
Trimethoprim-Sulfamethoxazole: The Present Position
1973
A Study of the Effectiveness of Rifaprim in Chronic prostatitis Caused Mainly by Staphylococcus Aureus
1982
Cefoxitin and Cephalothin: Antimicrobial Activity, Human Pharmacokinetics, and Toxicology
1974
PHARMACOKINETICS OF AMIKACIN IN INFANTS AND PRE‐SCHOOL CHILDREN
1979
Downregulation of CD28 surface antigen on CD4+ and CD8+ T lymphocytes during HIV-1 infection.
1994
Management of surgical infections.
1984
Clinical pharmacology of cefotaxime including penetration into bile, sputum, bone and cerebrospinal fluid
1980
Amikacin in Treatment of Infections Caused by Gram-Negative Bacteria Resistant to Gentamicin and Other Aminoglycosides: Clinical and Bacteriologic Results
1976
Emergence of resistant bacterial strains during treatment of infections in the respiratory tract.
1986
EFFECT OF CORTICOSTEROIDS ON COURSE OF GUILLAIN-BARRÉSYNDROME
1974